Lanean...
CTLA4Ig Improves Murine iTreg Induction via TGFβ and Suppressor Function In Vitro
Blockade of the CD28:CD80/86 costimulatory pathway has been shown to be potent in blocking T cell activation in vitro and in vivo. The costimulation blocker CTLA4Ig has been approved for the treatment of autoimmune diseases and transplant rejection. The therapeutic application of regulatory T cells...
Gorde:
| Argitaratua izan da: | J Immunol Res |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Hindawi
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6051081/ https://ncbi.nlm.nih.gov/pubmed/30057914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/2484825 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|